Master test-639

Melanoma: assessment and management (2015) NICE guideline NG14

Suspected cancer: recognition and referral (2015) NICE guideline NG12

Dabrafenib for treating unresectable or metastatic BRAF V600 mutation-positive melanoma (2014) NICE technology appraisal guidance 321

Electrochemotherapy for primary basal cell carcinoma and primary squamous cell carcinoma (2014) NICE interventional procedure guidance 478

Electrochemotherapy for metastases in the skin from tumours of non-skin origin and melanoma (2013) NICE interventional procedure guidance 446

Vemurafenib for treating locally advanced or metastatic BRAF V600 mutation-positive malignant melanoma (2012) NICE technology appraisal guidance 269

Ipilimumab for previously treated advanced (unresectable or metastatic) melanoma (2012) NICE technology appraisal guidance 268

Ambulight PDT for the treatment of non-melanoma skin cancer (2011) NICE medical technology guidance 6

Endoscopic radical inguinal lymphadenectomy (2011) NICE interventional procedure guidance 398

Skin cancer prevention (2011) NICE guideline PH32

Improving outcomes for people with skin tumours including melanoma (2010) Cancer service guidance

Photodynamic therapy for non-melanoma skin tumours (including premalignant and primary non-metastatic skin lesions) (2006) NICE interventional procedure guidance 155

Melanoma (BRAF V600E mutation positive, unresectable, metastatic) – dabrafenib and trametinib. NICE technology appraisal guidance (publication expected August 2016)